{"id":8110,"date":"2026-06-10T11:14:26","date_gmt":"2026-06-10T08:14:26","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=8110"},"modified":"2026-06-10T11:14:28","modified_gmt":"2026-06-10T08:14:28","slug":"gen1e-lifesciences-gen-1123-medicine-for-duchenne-muscular-dystrophy-dmd","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/gen1e-lifesciences-gen-1123-medicine-for-duchenne-muscular-dystrophy-dmd\/","title":{"rendered":"GEn1E Lifesciences ve GEn-1123: Duchenne Kas Distrofisi (DMD) i\u00e7in Yeni Bir Hassas T\u0131p Yakla\u015f\u0131m\u0131"},"content":{"rendered":"<p class=\"wp-block-paragraph\">ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA), yapay zeka destekli hassas t\u0131p alan\u0131nda uzmanla\u015fm\u0131\u015f, Faz 2 klinik a\u015famas\u0131ndaki bir biyoteknoloji \u015firketi olan GEn1E Lifesciences taraf\u0131ndan geli\u015ftirilen, ara\u015ft\u0131rma a\u015famas\u0131ndaki Duchenne Musk\u00fcler Distrofisi (DMD) tedavisi GEn-1123'ye hem Yetim \u0130la\u00e7 Stat\u00fcs\u00fc (ODD) hem de Nadir Pediatrik Hastal\u0131k Stat\u00fcs\u00fc (RPDD) vermi\u015ftir.<\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>\u0130\u00e7indekiler<\/h2><nav><ul><li><a href=\"#what-is-g-en-1-e-lifesciences\">GEn1E Lifesciences nedir?<\/a><\/li><li><a href=\"#understanding-duchenne-muscular-dystrophy-dmd\">Duchenne Kas Distrofisi (DMD) Hakk\u0131nda Bilgiler<\/a><ul><\/ul><\/li><li><a href=\"#what-is-g-en-1123\">GEn-1123 nedir?<\/a><ul><li><a href=\"#a-novel-oral-precision-therapy\">Yeni Bir A\u011f\u0131z \u0130\u00e7i Hassas Tedavi Y\u00f6ntemi<\/a><\/li><\/ul><\/li><li><a href=\"#how-does-g-en-1123-work\">GEn-1123 nas\u0131l \u00e7al\u0131\u015f\u0131r?<\/a><ul><li><a href=\"#targeting-inflammation-and-muscle-degeneration\">\u0130ltihaplanma ve Kas Dejenerasyonunu Hedefleme<\/a><ul><li><a href=\"#reduce-harmful-inflammation\">Zararl\u0131 \u0130ltihab\u0131 Azalt\u0131r<\/a><\/li><li><a href=\"#promote-muscle-survival\">Kas Ya\u015fam\u0131n\u0131 Destekler<\/a><\/li><li><a href=\"#support-regenerative-processes\">Yenileyici S\u00fcre\u00e7leri Destekler<\/a><\/li><li><a href=\"#potentially-reduce-fibrosis\">Fibrozu Potansiyel Olarak Azaltabilir<\/a><\/li><\/ul><\/li><\/ul><\/li><li><a href=\"#why-is-g-en-1123-different\">GEn-1123 neden farkl\u0131?<\/a><ul><li><a href=\"#mutation-independent-potential\">Mutasyondan Ba\u011f\u0131ms\u0131z Potansiyel<\/a><\/li><li><a href=\"#oral-administration\">A\u011f\u0131zdan uygulama<\/a><\/li><\/ul><\/li><li><a href=\"#fda-recognition-why-it-matters\">FDA Tan\u0131ma: Neden \u00d6nemli?<\/a><ul><li><a href=\"#orphan-drug-designation-odd\">Yetim \u0130la\u00e7 Tan\u0131m\u0131 (ODD)<\/a><\/li><li><a href=\"#rare-pediatric-disease-designation-rpdd\">Nadir Pediatrik Hastal\u0131k Tan\u0131m\u0131 (RPDD)<\/a><\/li><\/ul><\/li><li><a href=\"#current-development-status\">Mevcut Geli\u015ftirme Durumu<\/a><ul><li><a href=\"#is-g-en-1123-approved\">GEn-1123 onayl\u0131 m\u0131?<\/a><\/li><\/ul><\/li><li><a href=\"#what-could-g-en-1123-mean-for-the-dmd-community\">GEn-1123 varyant\u0131 DMD toplulu\u011fu i\u00e7in ne anlama gelebilir?<\/a><\/li><li><a href=\"#key-takeaways\">\u00d6nemli \u00c7\u0131kar\u0131mlar<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<h2 id=\"what-is-g-en-1-e-lifesciences\" class=\"wp-block-heading\">GEn1E Lifesciences nedir?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">GEn1E Lifesciences, Kaliforniya, Palo Alto merkezli, iltihapl\u0131, ba\u011f\u0131\u015f\u0131kl\u0131k sistemiyle ilgili ve nadir hastal\u0131klar i\u00e7in hassas ila\u00e7lar geli\u015ftirmeye odaklanm\u0131\u015f bir biyoteknoloji \u015firketidir. \u015eirket, yeni tedavi f\u0131rsatlar\u0131n\u0131 belirlemek i\u00e7in yapay zeka (YZ), biyobelirte\u00e7 analizi, \u00e7oklu omik verileri ve hastaya \u00f6zg\u00fc hastal\u0131k profillemesini bir araya getiriyor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u015eirketin tescilli GRID Platformu, karma\u015f\u0131k biyolojik verileri analiz etmek ve ara\u015ft\u0131rmac\u0131lar\u0131n yaln\u0131zca semptomlar\u0131 y\u00f6netmek yerine hastal\u0131\u011f\u0131n alt\u0131nda yatan mekanizmalar\u0131 ele alan hedefli tedaviler geli\u015ftirmelerine yard\u0131mc\u0131 olmak \u00fczere tasarlanm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"understanding-duchenne-muscular-dystrophy-dmd\" class=\"wp-block-heading\">Duchenne Kas Distrofisi (DMD) Hakk\u0131nda Bilgiler<\/h2>\n\n\n\n<h3 id=\"what-is-dmd\" class=\"wp-block-heading\">DMD Nedir?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Duchenne Kas Distrofisi (DMD), distrofin genindeki mutasyonlardan kaynaklanan nadir bir genetik hastal\u0131kt\u0131r. \u0130\u015flevsel distrofin proteini olmadan, kaslar zamanla giderek hasar g\u00f6r\u00fcr ve zay\u0131flar. Daha Fazlas\u0131n\u0131 Okuyun:\u00a0<a href=\"https:\/\/dmdwarrior.com\/tr\/what-is-duchenne\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne Nedir?<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DMD, iskelet kaslar\u0131n\u0131, kalbi ve solunum kaslar\u0131n\u0131 etkileyerek giderek artan sakatl\u0131\u011fa ve ciddi sa\u011fl\u0131k sorunlar\u0131na yol a\u00e7ar.<\/p>\n\n\n\n<h3 id=\"why-does-dmd-progress\" class=\"wp-block-heading\">DMD Neden \u0130lerler?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">DMD&#039;nin ilerlemesi yaln\u0131zca distrofin eksikli\u011finden kaynaklanmaz. Devam eden kas hasar\u0131na katk\u0131da bulunan \u00e7e\u015fitli biyolojik s\u00fcre\u00e7ler vard\u0131r, bunlar aras\u0131nda \u015funlar yer al\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kronik iltihaplanma<\/li>\n\n\n\n<li>Ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccresi infiltrasyonu<\/li>\n\n\n\n<li>Kas lifi \u00f6l\u00fcm\u00fc<\/li>\n\n\n\n<li>Kas yenilenmesinin bozulmas\u0131<\/li>\n\n\n\n<li>Fibrozis (yara dokusu olu\u015fumu)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu mekanizmalar birlikte kas bozulmas\u0131n\u0131 ve fonksiyonel gerilemeyi h\u0131zland\u0131r\u0131r.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/06\/gen-1123-duchenne-muscular-dystrophy-1-1024x576.jpg\" alt=\"GEn-1123, GEn1E Lifesciences taraf\u0131ndan geli\u015ftirilen, Duchenne kas distrofisi i\u00e7in deneysel bir oral tedavi y\u00f6ntemidir.\" class=\"wp-image-8114\" title=\"\" srcset=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/06\/gen-1123-duchenne-muscular-dystrophy-1-1024x576.jpg 1024w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/06\/gen-1123-duchenne-muscular-dystrophy-1-300x169.jpg 300w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/06\/gen-1123-duchenne-muscular-dystrophy-1-768x432.jpg 768w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/06\/gen-1123-duchenne-muscular-dystrophy-1-1536x864.jpg 1536w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/06\/gen-1123-duchenne-muscular-dystrophy-1-18x10.jpg 18w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/06\/gen-1123-duchenne-muscular-dystrophy-1-747x420.jpg 747w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/06\/gen-1123-duchenne-muscular-dystrophy-1-150x84.jpg 150w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/06\/gen-1123-duchenne-muscular-dystrophy-1-696x392.jpg 696w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/06\/gen-1123-duchenne-muscular-dystrophy-1-1068x601.jpg 1068w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2026\/06\/gen-1123-duchenne-muscular-dystrophy-1.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">GEn-1123, GEn1E Lifesciences taraf\u0131ndan Duchenne kas distrofisi i\u00e7in geli\u015ftirilmekte olan deneysel bir oral tedavidir.<\/figcaption><\/figure>\n\n\n\n<h2 id=\"what-is-g-en-1123\" class=\"wp-block-heading\">GEn-1123 nedir?<\/h2>\n\n\n\n<h3 id=\"a-novel-oral-precision-therapy\" class=\"wp-block-heading\">Yeni Bir A\u011f\u0131z \u0130\u00e7i Hassas Tedavi Y\u00f6ntemi<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">GEn-1123, GEn1E Lifesciences taraf\u0131ndan Duchenne kas distrofisi i\u00e7in geli\u015ftirilen, deneysel a\u015famada olan oral k\u00fc\u00e7\u00fck molek\u00fcll\u00fc bir terapidir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Distrofin \u00fcretimini do\u011frudan eski haline getirmeye odaklanan tedavilerin aksine, GEn-1123, hastal\u0131k ilerlemesini tetikleyen temel biyolojik s\u00fcre\u00e7leri ele almay\u0131 ama\u00e7lamaktad\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tedavi \u015fu anda geli\u015ftirme a\u015famas\u0131ndad\u0131r ve hem FDA Yetim \u0130la\u00e7 Stat\u00fcs\u00fc hem de Nadir Pediatrik Hastal\u0131k Stat\u00fcs\u00fc alm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"how-does-g-en-1123-work\" class=\"wp-block-heading\">GEn-1123 nas\u0131l \u00e7al\u0131\u015f\u0131r?<\/h2>\n\n\n\n<h3 id=\"targeting-inflammation-and-muscle-degeneration\" class=\"wp-block-heading\">\u0130ltihaplanma ve Kas Dejenerasyonunu Hedefleme<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">GEn-1123, &quot;\u00e7ift sinyal mod\u00fclat\u00f6r\u00fc&quot; olarak tan\u0131mlanmaktad\u0131r.\u201c<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Amac\u0131, DMD&#039;de kas hasar\u0131na katk\u0131da bulunan anormal inflamatuar sinyal yollar\u0131n\u0131 yeniden dengelemeye yard\u0131mc\u0131 olmakt\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bu terapinin amac\u0131 \u015funlard\u0131r:<\/p>\n\n\n\n<h4 id=\"reduce-harmful-inflammation\" class=\"wp-block-heading\">Zararl\u0131 \u0130ltihab\u0131 Azalt\u0131r<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">DMD kaslar\u0131 a\u015f\u0131r\u0131 iltihaplanma aktivitesi ile karakterizedir. S\u00fcrekli iltihaplanma, kas y\u0131k\u0131m\u0131na ve doku hasar\u0131na katk\u0131da bulunur.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GEn-1123, hastal\u0131k ilerlemesini k\u00f6t\u00fcle\u015ftirebilecek pro-enflamatuar yollar\u0131 d\u00fczenlemeyi ama\u00e7lamaktad\u0131r.<\/p>\n\n\n\n<h4 id=\"promote-muscle-survival\" class=\"wp-block-heading\">Kas Ya\u015fam\u0131n\u0131 Destekler<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Tedavi ayn\u0131 zamanda kas h\u00fccrelerini s\u00fcrekli hasardan korumaya yard\u0131mc\u0131 olabilecek hayatta kalmay\u0131 destekleyici biyolojik yollar\u0131 da desteklemek \u00fczere tasarlanm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<h4 id=\"support-regenerative-processes\" class=\"wp-block-heading\">Yenileyici S\u00fcre\u00e7leri Destekler<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">DMD&#039;den etkilenen kaslar\u0131n zamanla kendilerini onarma yetenekleri s\u0131n\u0131rl\u0131d\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GEn-1123, v\u00fccudun do\u011fal onar\u0131m tepkisini iyile\u015ftirebilecek rejeneratif mekanizmalar\u0131 desteklemeyi ama\u00e7lamaktad\u0131r.<\/p>\n\n\n\n<h4 id=\"potentially-reduce-fibrosis\" class=\"wp-block-heading\">Fibrozu Potansiyel Olarak Azaltabilir<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Fibrozis, sa\u011fl\u0131kl\u0131 kas dokusunun yerini yara dokusuyla de\u011fi\u015ftirerek kas fonksiyonunu azalt\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GEn-1123, dejenerasyon ve inflamasyonda rol oynayan yollar\u0131 hedefleyerek fibrozise ba\u011fl\u0131 ilerlemeyi s\u0131n\u0131rlamaya yard\u0131mc\u0131 olabilir.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"why-is-g-en-1123-different\" class=\"wp-block-heading\">GEn-1123 neden farkl\u0131?<\/h2>\n\n\n\n<h3 id=\"mutation-independent-potential\" class=\"wp-block-heading\">Mutasyondan Ba\u011f\u0131ms\u0131z Potansiyel<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">G\u00fcn\u00fcm\u00fczde kullan\u0131lan bir\u00e7ok DMD tedavisi, belirli genetik mutasyonlar\u0131 hedef almaktad\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GEn-1123, bir\u00e7ok DMD hastas\u0131nda ortak olan inflamatuar ve dejeneratif s\u00fcre\u00e7lere odaklanmaktad\u0131r; bu da hastan\u0131n mutasyon tipinden ba\u011f\u0131ms\u0131z olarak potansiyel olarak \u00f6nem ta\u015f\u0131mas\u0131n\u0131 sa\u011flamaktad\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Gelecekte yap\u0131lacak klinik \u00e7al\u0131\u015fmalar g\u00fcvenli\u011fi ve etkinli\u011fi do\u011frularsa, bu yakla\u015f\u0131m potansiyel olarak fayda g\u00f6rebilecek hasta say\u0131s\u0131n\u0131 art\u0131rabilir.<\/p>\n\n\n\n<h3 id=\"oral-administration\" class=\"wp-block-heading\">A\u011f\u0131zdan uygulama<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Bir di\u011fer ay\u0131rt edici \u00f6zellik ise GEn-1123&#039;nin a\u011f\u0131zdan al\u0131nan bir tedavi olarak geli\u015ftiriliyor olmas\u0131d\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A\u011f\u0131zdan uygulanan tedaviler, damar yoluyla uygulanan tedavilere k\u0131yasla hastalar ve aileleri i\u00e7in pratik avantajlar sunabilir.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"fda-recognition-why-it-matters\" class=\"wp-block-heading\">FDA Tan\u0131ma: Neden \u00d6nemli?<\/h2>\n\n\n\n<h3 id=\"orphan-drug-designation-odd\" class=\"wp-block-heading\">Yetim \u0130la\u00e7 Tan\u0131m\u0131 (ODD)<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA), Amerika Birle\u015fik Devletleri&#039;nde 200.000&#039;den az ki\u015fiyi etkileyen nadir hastal\u0131klar\u0131 tedavi etmeyi ama\u00e7layan terapilere Yetim \u0130la\u00e7 Stat\u00fcs\u00fc vermektedir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Faydalar\u0131 \u015funlar\u0131 i\u00e7erebilir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kalk\u0131nma te\u015fvikleri<\/li>\n\n\n\n<li>Potansiyel vergi indirimleri<\/li>\n\n\n\n<li>Azalt\u0131lm\u0131\u015f d\u00fczenleme \u00fccretleri<\/li>\n\n\n\n<li>Onaydan sonra yedi y\u0131la kadar pazar m\u00fcnhas\u0131rl\u0131\u011f\u0131<\/li>\n<\/ul>\n\n\n\n<h3 id=\"rare-pediatric-disease-designation-rpdd\" class=\"wp-block-heading\">Nadir Pediatrik Hastal\u0131k Tan\u0131m\u0131 (RPDD)<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">FDA&#039;ye ayr\u0131ca GEn-1123&#039;ye Nadir Pediatrik Hastal\u0131k Tan\u0131m\u0131 da verilmi\u015ftir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bu s\u0131n\u0131fland\u0131rma, \u00f6ncelikle \u00e7ocuklar\u0131 etkileyen ciddi hastal\u0131klar i\u00e7in ayr\u0131lm\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">E\u011fer tedavi nihayetinde d\u00fczenleyici onay al\u0131r ve FDA gereksinimlerini kar\u015f\u0131larsa, GEn1E, gelecekteki ila\u00e7 geli\u015ftirme programlar\u0131n\u0131 h\u0131zland\u0131rmaya yard\u0131mc\u0131 olabilecek \u00d6ncelikli \u0130nceleme Kuponu (PRV) almaya hak kazanabilir.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"current-development-status\" class=\"wp-block-heading\">Mevcut Geli\u015ftirme Durumu<\/h2>\n\n\n\n<h3 id=\"is-g-en-1123-approved\" class=\"wp-block-heading\">GEn-1123 onayl\u0131 m\u0131?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">HAYIR.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GEn-1123 halen ara\u015ft\u0131rma a\u015famas\u0131nda olan bir tedavidir ve Duchenne Musk\u00fcler Distrofisi tedavisi i\u00e7in FDA veya di\u011fer d\u00fczenleyici kurumlar taraf\u0131ndan hen\u00fcz onaylanmam\u0131\u015ft\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A\u015fa\u011f\u0131daki hususlar\u0131n belirlenmesi i\u00e7in ek klinik \u00e7al\u0131\u015fmalara ihtiya\u00e7 duyulacakt\u0131r:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Emniyet<\/li>\n\n\n\n<li>Verimlilik<\/li>\n\n\n\n<li>Optimal dozaj<\/li>\n\n\n\n<li>Uzun vadeli faydalar ve riskler<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"what-could-g-en-1123-mean-for-the-dmd-community\" class=\"wp-block-heading\">GEn-1123 varyant\u0131 DMD toplulu\u011fu i\u00e7in ne anlama gelebilir?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">DMD, \u00f6nemli \u00f6l\u00e7\u00fcde kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7lar\u0131 olan, ilerleyici bir hastal\u0131k olmaya devam etmektedir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Gen terapileri ve ekson atlama tedavileri baz\u0131 hastalar i\u00e7in tedavi se\u00e7eneklerini geni\u015fletmi\u015f olsa da, bir\u00e7ok bireyde hastal\u0131k ilerlemesi devam etmektedir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GEn-1123, iltihaplanma, dejenerasyon ve bozulmu\u015f rejenerasyonu hedefleyerek farkl\u0131 bir tedavi stratejisi sunmaktad\u0131r; bu biyolojik s\u00fcre\u00e7ler, hastal\u0131\u011f\u0131n seyri boyunca kas kayb\u0131na katk\u0131da bulunur.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Gelecekteki klinik \u00e7al\u0131\u015fmalar olumlu sonu\u00e7lar g\u00f6sterirse, GEn-1123, geli\u015fmekte olan DMD tedavi ortam\u0131na \u00f6nemli bir katk\u0131 sa\u011flayabilir.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"key-takeaways\" class=\"wp-block-heading\">\u00d6nemli \u00c7\u0131kar\u0131mlar<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>GEn1E Lifesciences, Duchenne kas distrofisi i\u00e7in deneysel bir oral tedavi olan GEn-1123&#039;yi geli\u015ftirmektedir.<\/li>\n\n\n\n<li>GEn-1123, zararl\u0131 iltihab\u0131 d\u00fczenlerken kaslar\u0131n hayatta kalmas\u0131n\u0131 ve yenilenmesini desteklemek \u00fczere tasarlanm\u0131\u015ft\u0131r.<\/li>\n\n\n\n<li>Bu tedavi, distrofin restorasyonundan ziyade hastal\u0131\u011f\u0131 tetikleyen biyolojik yollar\u0131 hedef almaktad\u0131r.<\/li>\n\n\n\n<li>FDA, hem Yetim \u0130la\u00e7 Stat\u00fcs\u00fc hem de Nadir Pediatrik Hastal\u0131k Stat\u00fcs\u00fc alm\u0131\u015ft\u0131r.<\/li>\n\n\n\n<li>GEn-1123 halen klinik geli\u015ftirme a\u015famas\u0131ndad\u0131r ve hen\u00fcz d\u00fczenleyici onay almam\u0131\u015ft\u0131r.<\/li>\n\n\n\n<li>Bu tedavi, mutasyondan ba\u011f\u0131ms\u0131z bir potansiyele sahip olabilir ve bu da onu geni\u015f bir DMD hasta yelpazesi i\u00e7in uygun hale getirebilir.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bu Sayfay\u0131 Takip Edin<\/strong>&nbsp;&gt;&gt;&gt;&nbsp;<a href=\"https:\/\/dmdwarrior.com\/tr\/dmd-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne i\u00e7in T\u00fcm Klinik Ara\u015ft\u0131rmalar<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) to GEn-1123, an investigational Duchenne Muscular Dystrophy (DMD) therapy being developed by GEn1E Lifesciences, a Phase 2 clinical-stage biotechnology company specializing in AI-driven precision medicine. What Is GEn1E Lifesciences? GEn1E Lifesciences is a biotechnology company [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":8113,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[819,680,817,815,816,820,195],"class_list":["post-8110","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-dmd-drug-development","tag-dmd-orphan-drugs","tag-dmd-treatment","tag-gen-1123","tag-gen1e-lifesciences","tag-oral-therapy","tag-orphan-drug"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/8110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=8110"}],"version-history":[{"count":2,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/8110\/revisions"}],"predecessor-version":[{"id":8115,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/8110\/revisions\/8115"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/8113"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=8110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=8110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=8110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}